Neuroscience Market Size, Share & Trends Analysis Report By Technology (Whole Brain Imaging, Neuromicroscopy, Electrophysiology), By Component, And Segment Forecasts, 2012 - 2020

Table of Content

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Neuroscience Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 - 2020
3.2.1 Market driver analysis
3.2.1.1 Rising disease burden of brain associated disorders
3.2.1.2 Advancement in research for translation of neuroscience to neuro-technology
3.2.1.3 Increasing investments by government for R&D activities
3.2.2 Market restraint analysis
3.2.2.1 Ethical regulations for animal welfare
3.3 Neuroscience market dynamics
3.4 Key opportunities prioritized
3.5 Industry analysis - Porter’s
3.6 Neuroscience PESTEL Analysis
Chapter 4 Neuroscience Market Qualitative Aspects
4.1 Neuroscience experimentation non-human primates usage, by species
4.2 Use of human and non-human models in electrophysiology and neuromicroscopy
Chapter 5 Global Neuroscience Technology Outlook
5.1 Global neuroscience revenue share, by technology, 2013 & 2020
5.2 Whole brain imaging
5.2.1 Whole brain imaging market, 2012 - 2020 (USD Million)
5.2.2 Structural brain imaging
5.2.2.1 Structural brain imaging market, 2012 - 2020 (USD Million)
5.2.3 Functional brain imaging
5.2.3.1 Functional brain imaging market, 2012 - 2020 (USD Million)
5.3 Neuro-microscopy
5.3.1 Neuro-microscopy 3月ket, 2012 - 2020 (USD Million)
5.3.2 Fluoroscence neuro-microscopy
5.3.2.1 Fluoroscence neuro-microscopy market, 2012 - 2020 (USD Million)
5.3.2.2 Confocal fluoroscence microscopy
5.3.2.2.1 Confocal fluoroscence microscopy market, 2012 - 2020 (USD Million)
5.3.2.3 Two-photon fluoroscence microscopy
5.3.2.3.1 Two-photon fluoroscence neuro-microscopy market, 2012 - 2020 (USD Million)
5.3.2.4 Epifluorescent fluoroscence microscopy
5.3.2.4.1 Epifluorescent fluoroscence microscopy market, 2012 - 2020 (USD Million)
5.3.2.5 TIRF fluoroscence neuro-microscopy
5.3.2.5.1 TIRF fluoroscence microscopy market, 2012 - 2020 (USD Million)
5.3.3 Electron neuro-microscopy
5.3.3.1 Electron neuro-microscopy market, 2012 - 2020 (USD Million)
5.3.3.2 Scanning electron neuro-microscopy
5.3.3.2.1 Scanning electron neuro-microscopy market, 2012 - 2020 (USD Million)
5.3.3.3 Electron tomography
5.3.3.3.1 Electron tomography market, 2012 - 2020 (USD Million)
5.3.3.4 Transmission electron neuro-microscopy
5.3.3.4.1 Transmission electron neuro-microscopy market, 2012 - 2020 (USD Million)
5.3.4 Light neuro-microscopy
5.3.4.1 Light neuro-microscopy market, 2012 - 2020 (USD Million)
5.4 Electrophysiology
5.4.1 Electrophysiology market, 2012 - 2020 (USD Million)
5.5 Neurofunctional visualization
5.5.1 Neurofunctional visualization market, 2012 - 2020 (USD Million)
5.6 Neuroproteomic analysis
5.6.1 Neuroproteomic analysis market, 2012 - 2020 (USD Million)
5.7 Neurocellular manipulation
5.7.1 Neurocellular manipulation market, 2012 - 2020 (USD Million)
5.8 Neuro biochemical assays
5.8.1 Neuro biochemical assays market, 2012 - 2020 (USD Million)
5.9 Stereotaxic surgeries
5.9.1 Stereotaxic surgeries market, 2012 - 2020 (USD Million)
5.9.2 Neural activity implants
5.9.2.1 Neural activity implants market, 2012 - 2020 (USD Million)
5.9.3 Long-term access implants
5.9.3.1 Long-term access implants market, 2012 - 2020 (USD Million)
5.9.4 Neurochemistry
5.9.4.1 Neurochemistry market, 2012 - 2020 (USD Million)
5.10 Animal behavior analysis
5.10.1 Animal behavior analysis market, 2012 - 2020 (USD Million)
5.10.2 Non-human primates related
5.10.2.1 Non-human primate related market, 2012 - 2020 (USD Million)
5.10.3 Rodent behavior related
5.10.3.1 Rodent behavior related market, 2012 - 2020 (USD Million)
5.10.4 Optogenetics actuators
5.10.4.1 Optogenetics actuators market, 2012 - 2020 (USD Million)
5.10.5 Optogenetics sensors
5.10.5.1 Optogenetics sensors market, 2012 - 2020 (USD Million)
5.10.6 Drosophila behavior related
5.10.6.1 Drosophila behavior related market, 2012 - 2020 (USD Million)
5.10.7 C.elegans related
5.10.7.1 C.elegans related market, 2012 - 2020 (USD Million)
Chapter 6 Neuroscience Outlook by Components
6.1 Global neuroscience revenue share, by components, 2013 & 2020
6.2 Instrumentation
6.2.1 Instrumentation market, 2012 - 2020 (USD Million)
6.3 Data analysis & services
6.3.1 Data analysis and services market, 2012 - 2020 (USD Million)
6.4 Consumables
6.4.1 Consumables market, 2012 - 2020 (USD Million)
Chapter 7 Neuroscience Regional Outlook
7.1 Neuroscience market revenue share, by region, 2013 & 2020
7.2 North America
7.2.1 North America neuroscience market, 2012 - 2020 (USD Million)
7.3 Europe
7.3.1 Europe neuroscience market, 2012 - 2020 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific neuroscience market, 2012 - 2020 (USD Million)
7.5 RoW
7.5.1 RoW neuroscience market, 2012 - 2020 (USD Million)
Chapter 8 Competitive Landscape
8.1 Doric Lenses Inc.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.2 GE Healthcare
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.3 Siemens
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.4 Laserglow Technologies
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Mightex Systems
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Prizmatix Ltd.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Kendall Research Systems LLC
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
8.8 Noldus Information Technology
8.8.1 Company Overview
8.8.2 Product Benchmarking
8.8.3 Strategic Initiatives
8.9 Mousera Inc.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiatives
8.10 Med Associates Inc.
8.10.1 Company Overview
8.10.2 Financial Performance
8.10.3 Product Benchmarking
8.11 Phoenix Research Laboratories
8.11.1 Company Overview
8.11.2 Financial Performance
8.11.3 Product Benchmarking
8.12 Biobserve GmbH
8.12.1 Company Overview
8.12.2 Financial Performance
8.12.3 Product Benchmarking
8.12.4 Strategic Initiatives
8.13 NeuroNexus Technologies
8.13.1 Company Overview
8.13.2 Financial Performance
8.13.3 Product Benchmarking
8.14 Multi Channel Systems MCS GmbH
8.14.1 Company Overview
8.14.2 Financial Performance
8.14.3 Product Benchmarking
8.14.4 Strategic Initiatives
8.15 Alpha Omega
8.15.1 Company Overview
8.15.2 Financial Performance
8.15.3 Product Benchmarking
8.15.4 Strategic Initiatives
8.16 Plexon Inc.
8.16.1 Company Overview
8.16.2 Financial Performance
8.16.3产品基准测试
8.16.4 Strategic Initiatives
8.17 TDT
8.17.1 Company Overview
8.17.2 Financial Performance
8.17.3 Product Benchmarking
8.18 Blackrock Microsystems LLC
8.18.1 Company Overview
8.18.2 Financial Performance
8.18.3 Product Benchmarking
8.18.4 Strategic Initiatives
8.19 Neuralynx Inc.
8.19.1 Company Overview
8.19.2 Financial Performance
8.19.3 Product Benchmarking
8.19.4 Strategic Initiatives
8.20 Thomas RECORDING GmbH
8.20.1 Company Overview
8.20.2 Financial Performance
8.20.3 Product Benchmarking
8.21 Intan Technologies
8.21.1 Company Overview
8.21.2 Financial Performance
8.21.3 Product Benchmarking
8.22 Axion Biosystems
8.22.1 Company Overview
8.22.2 Financial Performance
8.22.3 Product Benchmarking
8.22.4 Strategic Initiatives
8.23 Scientifica Ltd
8.23.1 Company Overview
8.23.2 Financial Performance
8.23.3 Product Benchmarking
8.24 Prairie Technologies (Bruker Corporation)
8.24.1 Company Overview
8.24.2 Financial Performance
8.24.3 Product Benchmarking
8.24.4 Strategic Initiatives
8.25 LaVision BioTec GmbH
8.25.1 Company Overview
8.25.2 Financial Performance
8.25.3 Product Benchmarking
8.25.4 Strategic Initiatives
8.26 Femtonics Ltd.
8.26.1 Company Overview
8.26.2 Financial Performance
8.26.3 Product Benchmarking
8.26.4 Strategic Initiatives
8.27 Sutter Instrument Corporation
8.27.1 Company Overview
8.27.2 Financial Performance
8.27.3 Product Benchmarking
8.28 Newport Corporation
8.28.1 Company Overview
8.28.2 Financial Performance
8.28.3 Product Benchmarking
8.29 Neurotar Ltd.
8.29.1 Company Overview
8.29.2 Financial Performance
8.29.3 Product Benchmarking
8.30 Trifoil Imaging Inc.
8.30.1 Company Overview
8.30.2 Financial Performance
8.30.3 Product Benchmarking
8.30.4 Strategic Initiatives
8.31 Mediso Medical Imaging Systems
8.31.1公司啊verview
8.31.2 Financial Performance
8.31.3 Product Benchmarking
8.31.4 Strategic Initiatives

List of Tables

TABLE 1 Neuroscience - Industry Snapshot & Key Buying Criteria, 2012 - 2020
TABLE 2 Global neuroscience market, by technology, 2012 - 2020 (USD Million)
TABLE 3 Global neuroscience market, by technology component, 2012 - 2020 (USD Million)
TABLE 4 Global neuroscience market, by region, 2012 - 2020 (USD Million)
TABLE 5 Global number of neuroscience laboratories & research organization, by region, 2012 - 2014
TABLE 6 Global average laboratory expenditure, by type, 2012 - 2014 (USD Million)
TABLE 7 Neuroscience key market driver analysis
TABLE 8 Estimated growth in geriatric population
TABLE 9 U.S. Annual Alzheimer’s death rates (per 100,000) by Age
TABLE 10 Neuroscience key market restraint analysis
TABLE 11 Comparison of marmosets and macaques
表12种不同种类的猕猴
TABLE 14 North America neuroscience market, by technology, 2012 - 2020 (USD Million)
表15北美整个大脑成像市场,by technology, 2012 - 2020 (USD Million)
TABLE 16 North America neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 17 North America fluorescence neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 18 North America electron neuromicroscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 19 North America stereotaxic surgery market, by technology, 2012 - 2020 (USD Million)
TABLE 20 North America animal behavior analysis market, by technology, 2012 - 2020 (USD Million)
TABLE 21 North America neuroscience market, by technology component, 2012 - 2020 (USD Million)
TABLE 22 Europe neuroscience market, by technology, 2012 - 2020 (USD Million)
TABLE 23 Europe whole brain imaging market, by technology, 2012 - 2020 (USD Million)
TABLE 24 Europe neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 25 Europe fluorescence neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 26 Europe electron neuromicroscopy market, by technology, 2012 - 2020 (USD Million)
表27个欧洲市场立体定位手术,侦探hnology, 2012 - 2020 (USD Million)
TABLE 28 Europe animal behavior analysis market, by technology, 2012 - 2020 (USD Million)
TABLE 29 Europe neuroscience market, by technology component, 2012 - 2020 (USD Million)
TABLE 30 Asia Pacific neuroscience market, by technology, 2012 - 2020 (USD Million)
TABLE 31 Asia Pacific whole brain imaging market, by technology, 2012 - 2020 (USD Million)
TABLE 32 Asia Pacific neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 33 Asia Pacific fluorescence neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 34 Asia Pacific electron neuromicroscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 35 Asia Pacific stereotaxic surgery market, by technology, 2012 - 2020 (USD Million)
TABLE 36 Asia Pacific animal behavior analysis market, by technology, 2012 - 2020 (USD Million)
TABLE 37 Asia Pacific neuroscience market, by technology component, 2012 - 2020 (USD Million)
TABLE 38 RoW neuroscience market, by technology, 2012 - 2020 (USD Million)
TABLE 39 RoW whole brain imaging market, by technology, 2012 - 2020 (USD Million)
TABLE 40 RoW neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 41 RoW fluorescence neuro-microscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 42 RoW electron neuromicroscopy market, by technology, 2012 - 2020 (USD Million)
TABLE 43 RoW stereotaxic surgery market, by technology, 2012 - 2020 (USD Million)
TABLE 44 RoW animal behavior analysis market, by technology, 2012 - 2020 (USD Million)
TABLE 45 RoW neuroscience market, by technology component, 2012 - 2020 (USD Million)

List of Figures

FIG. 1 Neuroscience market segmentation
FIG. 2 Global neuroscience market, 2012 - 2020 (USD Million)
FIG. 3 Global geriatric population, 2012 - 2020 (Million)
FIG. 4 Gross R&D investments (USD Billion PPP)
FIG. 5 Neuroscience market dynamics
FIG. 6 Key opportunities prioritized
FIG. 7 Neuroscience market - Porter’s analysis
FIG. 8 Neuroscience market PESTEL analysis
FIG. 9 Neuroscience revenue share, by technology, 2013 & 2020
FIG. 10 Whole brain imaging market, 2012 - 2020 (USD Million)
FIG. 11 Structural brain imaging market, 2012 - 2020 (USD Million)
FIG. 12 Functional brain imaging market, 2012 - 2020 (USD Million)
FIG. 13 Neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 14 Fluoroscence neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 15 Confocal fluoroscence microscopy market, 2012 - 2020 (USD Million)
FIG. 16 Two-photon fluoroscence neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 17 Epifluorescent fluoroscence microscopy market, 2012 - 2020 (USD Million)
FIG. 18 TIRF fluoroscence microscopy market, 2012 - 2020 (USD Million)
FIG. 19 Electron neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 20 Scanning electron neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 21 Electron tomography market, 2012 - 2020 (USD Million)
FIG. 22 Transmission electron neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 23 Light neuro-microscopy market, 2012 - 2020 (USD Million)
FIG. 24 Electrophysiology market, 2012 - 2020 (USD Million)
FIG. 25 Neurofunctional visualization market, 2012 - 2020 (USD Million)
FIG. 26 Neuroproteomic analysis market, 2012 - 2020 (USD Million)
FIG. 27 Neurocellular manipulation market, 2012 - 2020 (USD Million)
FIG. 28 Neuro biochemical assays market, 2012 - 2020 (USD Million)
FIG. 29 Stereotaxic surgeries market, 2012 - 2020 (USD Million)
FIG. 30 Neural activity implants market, 2012 - 2020 (USD Million)
FIG. 31 Long-term access implants market, 2012 - 2020 (USD Million)
FIG. 32 Neurochemistry market, 2012 - 2020 (USD Million)
FIG. 33 Animal behavior analysis market, 2012 - 2020 (USD Million)
FIG. 34 Non-human primate related market, 2012 - 2020 (USD Million)
FIG. 35 Rodent behavior related market, 2012 - 2020 (USD Million)
FIG. 36 Optogenetics actuators market, 2012 - 2020 (USD Million)
FIG. 37 Optogenetics sensors market, 2012 - 2020 (USD Million)
FIG. 38 Drosophila behavior related market, 2012 - 2020 (USD Million)
FIG. 39 C.elegans related market, 2012 - 2020 (USD Million)
FIG. 40 Neuroscience revenue share, by technology, 2013 & 2020
FIG. 41 Instrumentation market, 2012 - 2020 (USD Million)
FIG. 42 Data analysis market, 2012 - 2020 (USD Million)
FIG. 43 Consumables market, 2012 - 2020 (USD Million)
FIG. 44 Neuroscience market share, by region, 2013 & 2020
FIG. 45 North America neuroscience market, 2012 - 2020 (USD Million)
FIG. 46 Europe neuroscience market, 2012 - 2020 (USD Million)
FIG. 47 Asia Pacific neuroscience market, 2012 - 2020 (USD Million)
FIG. 48 RoW neuroscience market, 2012 - 2020 (USD Million)